Feedback / Questions
STC-1010 - Brenus Pharma
https://www.businesswire.com/news/home/20260106391108/en/Brenus-Pharma-Reports-Favorable-Tolerability-and-Clinical-Signals-in-Early-Preliminary-Results-of-First-In-Human-Study-for-STC-1010-in-Unresectable-Metastatic-Stage-Colorectal-Cancer-MSS-CRC-Patients
Jan 6, 2026
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next